U.S. Banks Stock News

Mid-America Apartment Communities (MAA) is back in focus as analysts update their views, the REIT prepares to report upcoming earnings, and insiders execute planned share sales alongside a recently confirmed quarterly dividend. See our latest analysis for Mid-America Apartment Communities. The recent 1-day share price return of 1.44% and 7-day gain of 2.89% to US$126.09 sit against a weaker backdrop, with a 30-day share price return of 4.58% and a 1-year total shareholder return of 16.66%...

Kura Sushi USA (KRUS) opened Q2 2026 with revenue of US$80.0 million, a basic EPS loss of US$0.14, and net income loss of US$1.7 million, setting the tone for another quarter where top line growth is front and center while profitability remains under pressure. The company has reported quarterly revenue increasing from US$64.9 million in Q2 2025 to US$80.0 million in Q2 2026, while basic EPS moved from a loss of US$0.31 to a loss of US$0.14 over the same period, alongside a trailing twelve...

AI runs on real world hardware, and right now that physical backbone is where a lot of the attention is going. While energy prices, interest rate expectations, and geopolitical tensions are keeping many sectors on edge, the companies building data centers, power connections, and cooling systems are dealing in tangible demand. The AI Infrastructure Stocks screener focuses on those providers that are turning sales into cash flow, instead of just selling a story. In this article, you will see 3...

In recent months, hedge funds such as Duquesne Capital have been increasing their positions in BBB Foods Inc. (NYSE:TBBB), while the company has expanded its Mexican grocery footprint by opening 574 net new stores during 2025. This combination of rising institutional ownership and rapid store rollout highlights how investors are focusing on BBB Foods’ potential to win customers from traditional mom-and-pop retailers through scale and private-label offerings. Next, we will examine how BBB...

Markets are being pulled in different directions by energy prices, interest rate expectations, and shifting inflation trends, and that can make it harder to know where to focus. One clear anchor is leadership that is deeply invested in its own business. Founder led companies, where leaders typically hold meaningful stakes and think in decades rather than quarters, can offer a different quality of commitment. This article looks at our Top Founder Led Companies screener and highlights three...

Nurix Therapeutics (NRIX) opened 2026 with Q1 revenue of US$6.3 million and a basic EPS loss of US$0.79, while trailing twelve month figures show revenue of US$71.8 million against a basic EPS loss of US$3.17, framing a business that is still firmly in investment mode. Over the past year, the company has seen quarterly revenue range from US$6.3 million to US$44.1 million and basic EPS move between a loss of US$0.52 and a loss of US$1.03, giving investors a clear view of how top line progress...

Kiniksa Pharmaceuticals International (NasdaqGS:KNSA) has launched Heart’s Home, a Direct-to-Consumer campaign focused on ARCALYST for recurrent pericarditis. The campaign aims to expand awareness and empower patients about the only FDA approved therapy for recurrent pericarditis. Heart’s Home represents a new commercial effort to reach patients directly outside the traditional physician focused model. Kiniksa Pharmaceuticals International, listed on NasdaqGS:KNSA, develops and...

BOK Financial (NasdaqGS:BOKF) has promoted Scott Andrews to lead its Specialized Industries Banking group. The appointment follows the planned retirement of Executive Vice President Brad Vincent. The transition affects key lines of business including commercial real estate, energy, and healthcare banking. BOK Financial’s Specialized Industries Banking unit sits at the core of its commercial franchise, with exposure to sectors that tend to be closely watched by lenders and regulators. Areas...

Aehr Test Systems (AEHR) has released its Q3 2026 numbers, reporting revenue of US$10.3 million and a basic EPS loss of US$0.10, alongside net income excluding extra items of a US$3.2 million loss. The company has seen quarterly revenue move between US$13.5 million and US$18.3 million since Q2 2025, while basic EPS has ranged from a profit of US$0.78 per share on a trailing twelve month basis in 2025 to a loss of US$0.38 per share over the most recent twelve month window. This keeps the focus...

If you are wondering whether PagSeguro Digital's current share price truly reflects its underlying worth, this article walks through the key signals you can use to judge that. The stock recently closed at US$10.76, with returns of 2.2% over the last 7 days, 7.8% over 30 days, 11.3% year to date, 35.4% over 1 year, 31.3% over 3 years and a 75.3% decline over 5 years. Recent coverage has focused on PagSeguro Digital's position within diversified financials and how changing views on digital...

CVB Financial received final regulatory approval for its merger with Heritage Commerce. The companies now have clearance to close the transaction, which is expected to happen imminently. The approval moves the combination from planning to full integration for customers, employees, and shareholders. For investors tracking CVB Financial, ticker NasdaqGS:CVBF, the timing of this approval comes with the stock at $20.3 and a value score of 4. Over the past year the shares have returned 20.8%,...

Royalty Pharma (RPRX) is back in focus after announcing a US$500 million R&D co funding agreement with Johnson & Johnson to advance JNJ-4804, an investigational autoimmune therapy targeting IL-23 and TNF pathways. See our latest analysis for Royalty Pharma. The J&J co funding news lands on top of an already strong run, with Royalty Pharma’s 90 day share price return of 18.98% and 1 year total shareholder return of 51.96% suggesting momentum has been building. If this kind of deal making has...

Event driven snapshot of Gibraltar Industries With no single headline event setting the tone, Gibraltar Industries (ROCK) draws attention through its recent trading performance, mixed short term and multi month returns, and value focused metrics that many investors are reassessing. See our latest analysis for Gibraltar Industries. The recent 5.35% 1-day share price return and 2.50% 7-day share price return contrast with a 90-day share price return decline of 21.39% and a 1-year total...

Event context and recent price action HeartFlow (HTFL) has attracted fresh attention after a recent uptick in its share price, building on a 0.8% gain over the past day and a 10.5% move across the past week. That short term strength sits alongside a 16.8% rise over the past month, set against a 19.1% decline across the past 3 months and a 6.5% negative return year to date. Together, these figures give investors a mixed recent picture. See our latest analysis for HeartFlow. Putting that into...

Nadia Karkar has left TPG Rise to become a Managing Partner at 500 Global. She previously led global business development and TPG Rise's Global South Initiative. Her departure affects TPG's climate focused investing and relationships in emerging markets. TPG, traded as NasdaqGS:TPG, is in the spotlight after this leadership change within its impact investing arm. The shares most recently closed at $38.26, with a 3 year return of 47.4% and a 1 year return of a 13.4% decline. The stock is...

Cinemark Holdings recently reported that it achieved an all-time high five-day Easter weekend domestic box office, powered by a diverse film slate and exceptionally strong attendance led by The Super Mario Galaxy Movie. The company also delivered its best-ever merchandise program tied to the film, suggesting that immersive activations and themed food and beverage can materially boost non-ticket revenue and deepen audience engagement. We’ll now examine how this record Easter performance,...

Xometry recently announced its Enterprise Machining Lead Time Prediction Model and upgraded dynamic pricing, while Thomas partnered with Maryland Manufacturing Extension Partnership to support manufacturers’ digital adoption in the state. Together, these AI enhancements and ecosystem partnerships highlight Xometry’s push to deepen its role in digitally enabled, resilient manufacturing supply chains. Next, we’ll examine how the new AI lead time model may reshape Xometry’s investment narrative...

If you are wondering whether CoreWeave's current share price still offers value, this breakdown will help you weigh what you are paying against what you are getting. The stock last closed at US$88.90, with returns of 13.3% over 7 days, 19.5% over 30 days, 12.1% year to date, and 82.3% over 1 year. These returns have likely caught the attention of both new and existing investors who are reassessing risk and reward. Recent coverage has focused on CoreWeave's role in AI infrastructure and its...

Why Confluent (CFLT) is in focus now Confluent (CFLT) is back in the spotlight after disclosing reduced cloud usage from a major AI native customer and facing an investor investigation into possible securities law violations and related business conduct. See our latest analysis for Confluent. After the disclosure about reduced cloud usage and the legal probe, investors have already experienced some volatility, yet Confluent’s 16.94% 1 year total shareholder return and 48.99% 3 year total...

RPM International (RPM) just posted Q3 2026 results with revenue of US$1.6b and basic EPS of US$0.40, alongside net income excluding extra items of US$51.4m, putting fresh numbers around a year that also includes trailing 12 month revenue of US$7.7b and EPS of US$5.21. Over the past few quarters, the company has seen revenue move from US$1.48b in Q3 2025 to US$2.11b in Q1 2026 before landing at US$1.61b in the latest quarter. Basic EPS has ranged from around US$0.41 to US$1.78 across that...

In early April 2026, Citigroup downgraded Bio-Rad Laboratories’ rating from “Buy” to “Neutral,” signaling a shift in analyst sentiment toward the life science and clinical diagnostics company. This reassessment comes as Bio-Rad is cited among key players in the rapidly expanding single-cell omics market, where demand for advanced tools in cancer, immunology, and stem cell research is intensifying. We’ll now examine how Citigroup’s downgrade, against a backdrop of growing single-cell omics...

If you are wondering whether StoneX Group's current share price reflects its real worth, the recent trading history gives you plenty to think about. The stock last closed at US$91.62, with returns of 13.4% over 7 days, 26.0% over 30 days, 41.1% year to date, 80.3% over 1 year, 204.9% over 3 years, and 372.3% over 5 years. Recent headlines have focused on StoneX Group as a diversified financial services provider operating across capital markets and related services. This helps explain why...

If you are wondering whether Ralph Lauren's recent share price puts it at a stretch or still leaves room for value, the key is understanding how the current market price compares with what the business may be worth. The stock last closed at US$375.40, with returns of 6.3% over 7 days, 9.1% over 30 days, 3.6% year to date and 82.3% over the past year, with longer term returns of 233.6% over 3 years and 231.1% over 5 years. Recent headlines around Ralph Lauren have focused on its positioning...

Phoenix Education Partners (PXED) just posted its Q2 2026 numbers with revenue of US$222.5 million, Basic EPS of US$0.30 and net income of US$10.8 million. This sets the tone against a trailing twelve month picture that includes US$1.0 billion in revenue and Basic EPS of US$2.74 on net income of US$97.6 million. Over recent quarters, the company has seen revenue move between US$254.7 million and US$262.0 million, with Basic EPS ranging from US$0.43 to US$1.31. This provides a clearer view of...